Probiotics and prebiotics: Can regulating the activities of intestinal bacteria benefit health?

Western Journal of Medicine

Volumn 171, Issue 3, 1999, Pages 187-191

  Macfarlane, George T ^a,b   Cummings, John H ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042126741     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-982.
2. Christi SU, Gibson GR, Cummings JH. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992;33:1234-1238.
3. Sussman J, Baron E, Goldberg S, et al. Clinical manifestations of lactobacillus endocarditis: report of a case and review of the literature. Rev Infect Dis 1986;8:771-776.
4. Hata D, Yoshida A, Ohkubo H, et al. Meningitis caused by bifidobacterium in an infant. Pediatr Infect Dis J 1988;7:669-671.
5. Gibson GR, Saavedra JM, Macfarlane S, Macfarlane GT. Gastrointestinal microbial disease and probiotics. In: Fuller R, editor. Probiotics: therapeutic and other beneficial effects. London: Chapman and Hall; 1997. p. 10-39.
6. Deguchi Y, Morishita T, Mutai M. Comparative studies on synthesis of water-soluble vitamins among human species of bifidobacteria. Agric Biol Chem 1985;49:13-19.
7. Bullen CL, Willis AT. Resistance of the breast-fed infant to gastroenteritis. Br Med J 1971;3:338-343.
8. Fuller R. A review: probiotics in man and animals. J Appl Bacteriol 1989;66:365-378.
9. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-489.
10. Bernet M-F, Brassart D, Neeser J-R, Servin AL. Adhesion of human bifidobacterial strains to cultured human epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 1993;59:4121-4128.
11. Johansson M-L, Molin G, Jeppsson B, et al. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993;59:15-20.
12. Yamazaki S, Kamimura H, Momose H, et al. Protective effect of bifidobacterium monoassociation against lethal activity of E coli. Bifidobacteria and Microflora 1982;1:55-60.
13. Tojo M, Oikawa T, Morikawa Y, et al. The effects of Bifidobacterium breve administration on campylobacter enteritis. Acta Pediatr Jpn 1987;29:160-167.
14. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046-1049.
15. Gotz V, Romankiewics JA, Moss J, Murray HW Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979;30:754-757.
16. Aronsson B, Barany P, Nord CE. Clostridium difficile-associated diarrhoea in uremic patients. Eur J Clin Microbiol 1987;6:352-356.
17. Gorbach SL, Chang T, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;ii:1519.
18. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231-1233.
19. Clements ML, Levine MM, Black RE, et al. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob Agents Chemother 1981;20:104-108.
20. Surawicz CM, Elmer G, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;9:981-988.
21. Kollaritsch H, Wiedermann G. Traveller's diarrhoea among Austrian tourists: epidemiology, clinical features and attempts at nonantibiotic drug prophylaxis. In: Pasini W, editor. Proceedings of the second international conference on tourist health. 1990; Rimini, Italy: World Health Organization; 1990. p. 74-82.
22. Black FT, Andersen PL, Orskov J, et al. Prophylactic efficacy of lactobacilli on traveller's diarrhea. In: Steffen R, editor. Travel medicine: conference on international travel medicine. 1989. Berlin: Springer; 1989. p. 333-335.
23. Stone-Dorshow T, Levitt MD. Gaseous response to ingestion of a poorly absorbed fructooligosaccharide sweetener. Am J Clin Nutr 1987;46:61-65.
24. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994;77:412-420.
25. Hidaka H, Eida T, Takizawa T, et al. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria and Microflora 1986;5:37-50.
26. Hayakawa K, Mizutani J, Wada K, et al. Effects of soybean oligosaccharides on human faecal microflora. Microb Ecol Health Dis 1990;3:293-303.
27. McBain AJ, Macfarlane GT. Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. Scand J Gastroenterol 1997;32:32-40.
28. Ito M, Deguchi Y, Miyamori A, et al. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990;3:285-292.
29. Zang XB, Ohta Y, Hosono A. Antimutagenicity and binding of lactic bacteria from a Chinese cheese to mutagenic pyrolyzates. J Diary Sci 1990;73:2702-2710.
30. Rowland IR, Grasso P. Degradation of N-nitrosamines by intestinal bacteria. Appl Microbiol 1975;29:7-12.
31. Challa A, Ramkishan Rao D, Chawa CB, Shackleford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 1997;18:517-521.
32. Sekine K, Watanabe-Sekine E, Ohta J, et al. Induction and activation of tumoricidal cells in vitro and in vivo by the bacterial cell wall of Bifidobacterium infantis. Bifidobacteria and Microflora 1994;13:65-77.
33. Koo OM, Rao AV. Long-term effect of bifidobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice. Nutr Rev 1991;51:137-146.
34. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo [[4,5-f]] quinoline, a food mutagen. Cancer Res 1993;53:3914-3918.
35. Buddington RK, Williams CH, Chen S-C, Witherly SA. Dietary supplement of Neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996;63:709-716.
36. Famularo G, Moretti S, Marcellini S, De Simone C. Stimulation of immunity by probiotics. In: Fuller R, editor. Probiotics: therapeutic and other beneficial effects. London: Chapman and Hall, 1997. p. 133-161.
37. Schiffrin EJ, Brassart D, Servin AL, et al. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997;66(suppl):15S-20S.
38. Standiford TK, Arenberg DA, Danforth JM, et al. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun 1994;62:119-125.
39. Op den Camp HJM, Oosterhof A, Veerkamp JH. Interaction of bifidobacterial lipoteichoic acid with human intestinal epithelial cells. Infect Immun 1984;47:332-334.
40. Kleeman EG, Klaenhammet TR. Adherence of Lactobacillus species to human fetal intestinal cells. J Dairy Sci 1982;65:2063-2069.
41. Perdigon G, de Macios ME, Alvarez S, et al. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 1986;53:404-410.
42. Matsumara K, Kitazawa H, Itoh T, Yamaguchi T. Interferon induction by murine peritoneal macrophage stimulated with Lactobacillus gasseri. Animal Sci Technol (Jpn) 1992;63:1157-1159.
43. Solis Pereyra B, Lemmonier D. Induction of human cytokines to bacteria used in dairy foods. Nutr Res 1993;13:1127-1140.
44. Yasui H, Ohwaki M. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 1991; 74:1187-1195.
45. Yasui H, Nagaoka N, Mike A, et al. Detection of bifidobacterium strains that induce large quantities of IgA. Microb Ecol Health Dis 1992;5:155-162.
46. De Simone C, Ciardi A, Grassi A, et al. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992;14:331-340.
47. Majamaa H, Isolaurie E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-185.
48. Hopkins MJ, Cummings JH, Macfarlane GT. Interspecies differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbon sources. J Appl Microbiol 1998;85:381-386.